PharmaLectures.com

Courses › Pharma training by country › First 90 days on the Europe desk: a plan for the Japanese export manager

First 90 days on the Europe desk: a plan for the Japanese export manager

Your Europe desk files dossiers that clear validation and stops losing launch dates.

  • 6 audio modulesthree lengths each
  • 1 h to 5 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Japan companieswho it is written for

Why this training matters

A batch from your Japanese plant reaches the European importer, and the Qualified Person will not certify it because the batch file lacks what Annex 16 asks for. The distributor calls about the launch date. Nobody on your desk knew the question was coming.

What changes after this course

Your desk picks the right procedure under Directive 2001/83/EC, files a dossier built to clear validation, and answers authority questions in one reply. You hold a certificate for each learner and a training record per person to show any inspector.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your export manager picks the marketing authorization route in one sitting, without waiting for outside counsel. Centralised under Regulation 726/2004, mutual recognition or decentralised under Directive 2001/83/EC: the choice follows from the product and the launch plan. The Article 8(3) particulars go to named people before the first page is written.

In the quality office, procedures get rewritten against Part I of the European Good Manufacturing Practice guide, starting with Chapter 1 on the Pharmaceutical Quality System and Chapter 4 on documentation. Batch files reach the importer's Qualified Person already answering what Annex 16 requires before certification, so release stops waiting on a phone call from Europe.

Packs leave your line carrying the unique identifier and anti-tampering device that Directive 2011/62/EU introduced and Delegated Regulation 2016/161 sets out in detail, for the medicines they cover. Your logistics people know which products are in scope. A recall request from a competent authority meets a file already built on Chapter 8 of Part I.

Dossier writers lay out the Common Technical Document so validation finds Module 1 complete and Module 3 in order, with the Module 2 overview linked to the clinical data. When a national competent authority sends questions, the reply closes them. Serious adverse drug reactions reach EudraVigilance within the 15-day limit that the EU pharmacovigilance rules set.

Who needs this training

  • Japanese Export Manager for Europe

    The first question from a national competent authority lands in your inbox. You decide what to answer, what to attach and how fast, without opening your marketing authorization to a wider review.

  • Quality Assurance Lead for European Exports

    The importer's Qualified Person asks for the batch file again, and each query traces back to a procedure written for another inspectorate. You rewrite it once against Part I and Annex 16.

  • Regulatory Affairs Specialist for European Markets

    You are assembling the first dossier and need Modules 1 to 5 placed where validation looks for them, so the file is not sent back for a formatting fault.

  • Supply Chain Logistics Coordinator

    A pallet is ready to leave, and you need to know whether the packs carry what Directive 2011/62/EU requires before the importer finds out for you.

Roles: Business development and export sales, Human resources and onboarding

Businesses: every kind of pharma company

Countries: Japan

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the centralised, mutual recognition and decentralised routes for your product and write down the reason for the choice.
  2. Check a Japanese quality manual against Part I of European Good Manufacturing Practice and list the gaps an inspector would cite.
  3. Assemble a batch file that gives the importer's Qualified Person what Annex 16 requires for certification.
  4. Decide whether a product falls under the safety feature rules of Directive 2011/62/EU and brief the packaging team.
  5. Arrange Module 1 and Module 3 of a Common Technical Document so reviewers find each item where they expect it.
  6. Draft a reply to a national competent authority that answers the question asked and nothing else.
  7. File a serious adverse drug reaction report in EudraVigilance inside the 15-day limit and keep proof of the date.

What the company gets

  • Your export department stops losing launch dates to paperwork that a Qualified Person or a competent authority sends back.
  • Your procedures are rewritten against Part I of European Good Manufacturing Practice, so an inspector finds documents that match what your people do.
  • You hold a training record for each person on the Europe desk and a certificate for each learner, ready to show an inspector or a European partner.
  • Your packs match Directive 2011/62/EU and your recall file follows Chapter 8 of Part I, so a held shipment or a Friday recall call meets an answer that is already prepared.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 6 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 30 min25 min a module, for regulatory, quality and business-development staff
Expanded5 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h
Human resources and onboardingBriefing1 h

Course outline: 6 modules

6 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Choose the right marketing authorization route under Directive 2001/83/EC

    • Why the centralised procedure is mandatory for some products and optional for others, and which yours is.
    • How to compare mutual recognition and decentralised procedures before you commit a launch date to either.
    • The Article 8(3) particulars your first application must carry, and who on your desk owns each.
  2. 2Align your quality system with European Good Manufacturing Practice Part I

    • Why a quality manual that passes at home can still draw findings from a European inspector.
    • How to build a batch file that lets the importer's Qualified Person certify under Annex 16 first time.
    • The Product Quality Review that Part I expects, and what to ask your contract manufacturers to hand over.
  3. 3Build a supply chain that meets Falsified Medicines Directive 2011/62/EU

    • What to do when a pack lacks its unique identifier or anti-tampering device before it leaves your line.
    • When the safety features apply to your medicine and when they do not, before anyone reprints a pack.
    • How to set up the recall file so a Friday afternoon call from a competent authority has an answer.
  4. 4Structure your Common Technical Document to clear the validation phase

    • Why Module 3 draws questions at validation, and the checks that stop them before you submit.
    • How to assemble the Module 1 regional documents so validation does not stop on a missing form.
    • The Module 2 cross-references that let a reviewer reach your Module 5 data by link.
  5. 5Answer national competent authority questions without adding delay

    • How to word a reply to a national competent authority so it closes the question.
    • What a reviewer is asking when a stability data question arrives, and the answer that ends it.
    • When to ask the authority for more time during a clock-stop and when to answer on the spot.
  6. 6Report adverse drug reactions to EudraVigilance before inspectors ask

    • The 15-day and 90-day reporting clocks, and which of your people starts each one.
    • How to write a Corrective and Preventive Action plan that an inspector accepts as closed.
    • Why a late safety report is a finding in itself, and the log that shows yours were on time.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

6 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h in the briefing length and 5 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Japan companies. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 54 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team